Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

13.53
+0.01500.11%
Post-market: 13.650.1200+0.89%19:53 EDT
Volume:1.99M
Turnover:26.83M
Market Cap:1.61B
PE:-13.01
High:13.93
Open:13.50
Low:13.15
Close:13.52
Loading ...
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 05, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 28, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 07, 2022

Major Issues Report

8-K - Current report
Sep 06, 2022

Major Issues Report

8-K - Current report
Aug 26, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 09, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 08, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership